Moleculin Biotech (MBRX)
(Delayed Data from NSDQ)
$4.63 USD
+0.32 (7.47%)
Updated Apr 26, 2024 03:56 PM ET
After-Market: $4.48 -0.15 (-3.24%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-3.59 | 0.00% |
Earnings Summary
For their last quarter, Moleculin Biotech (MBRX) reported earnings of -$2.85 per share, beating the Zacks Consensus Estimate of $-3.15 per share. This reflects a positive earnings surprise of 9.52%. Look out for MBRX's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$3.59 per share, reflecting a year-over-year increase of 14.52%.
Earnings History
Price & Consensus
Zacks News for MBRX
Moleculin (MBRX) Up 7% on Upbeat Updates From Annamycin Studies
MBRX: What are Zacks experts saying now?
Zacks Private Portfolio Services